Cerebralcare Granule® enhances memantine hydrochloride efficacy in APP/PS1 mice by ameliorating amyloid pathology and cognitive functions

• Main Authors: Ou Qiao (Author), Xinyu Zhang (Author), Yi Zhang (Author), Haixia Ji (Author), Zhi Li (Author), Xiaoying Han (Author), Wenzhe Wang (Author), Xia Li (Author), Juan Wang (Author), Changxiao Liu (Author), Wenyuan Gao (Author)
• Format: Book
• Published: BMC, 2021-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by memory deficits and cognitive decline. Current drugs can only relieve symptoms, but cannot really cure AD. Cerebralcare Granule® (CG) is a Traditional Chinese medicine (TCM) containing a var...